All lobbying filings

ARNOLD & PORTER KAYE SCHOLER LLP

Lobbying for EXELIXIS, INC. · Oncology-focused biotechnology company

Filing 4th Quarter - Report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 16, 2026

Income

$60,000.00

What the client paid this registrant for the period.

Client based in

California

Official filing document

Government bodies contacted 2

HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 2

S 1930
Small Biotech Innovation Act
HR 3731
Small Biotech Innovation Act

Lobbying activity 2

Medicare/Medicaid

Issues related to access, coverage, and payment for cancer drugs. Issues regarding the Inflation Reduction Act (P.L. No. 117-169), including implementation. Issues related to the Small Biotech Innovation Act (S. 1930 / H.R. 3731).

Health Issues

Issues related to access, coverage, and payment for cancer drugs. Issues regarding the 340B program.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.